Surgery News and Research

RSS

Enrollment complete in Dune Medical Devices' MarginProbe pivotal clinical trial

Dune Medical Devices today announced the completion of patient enrollment in the MarginProbe™ pivotal clinical trial. The MarginProbe procedure provides surgeons with real-time detection of cancer at the edges of the tissue removed during breast conservation surgery (BCS), which is the only way to ensure the complete removal of the tumor from the breast. The randomized, controlled trial includes 664 women who underwent BCS at one of 21 leading medical facilities, with 18 in the US and three in Israel.

12 Jan 2010

Frimley Park Hospital NHS Foundation Trust implements Picis software solutions

Picis today announced that Frimley Park Hospital NHS Foundation Trust in Surrey, England has successfully implemented Picis integrated surgical, anesthesia, recovery room and critical care software solutions.

12 Jan 2010

Obese patients at greater risk of developing renal cell cancer

Being obese could lead to a greater risk of developing the most common form of renal cell cancer, according to research in the January issue of the UK-based urology journal BJUI.

12 Jan 2010

Tocotrienol form of vitamin E prevents neural cell death and rescues the brain after stroke injury

Blocking the function of an enzyme in the brain with a specific kind of vitamin E can prevent nerve cells from dying after a stroke, new research suggests.

12 Jan 2010

Stem Cell Assurance announces availability of adipose-derived regenerative cell applications

Stem Cell Assurance, a company providing adult cell banking services and regenerative cell cosmetic and therapeutic procedures for individual clients, today announced the availability of adipose-derived regenerative cell applications through its elite physician network.

12 Jan 2010

University Hospitals in Cleveland selects Sectra as PACS provider

University Hospitals in Cleveland, Ohio has selected the IT and medical-technology company Sectra as their PACS provider. University Hospitals has been recognized by Thomson Reuters as a Top 10 hospital system in the U.S., and by U.S. News and World Report as one of America’s best hospitals.

12 Jan 2010

U-M Congenital Heart Center invites parents to submit queries on heart defect surgeries

The public, including parents of babies with severe heart defects, are invited to submit questions for inclusion in a tweet chat about surgical approaches for heart defects from noon-2 p.m. Wednesday, Jan. 20 on Twitter.

12 Jan 2010

CEL-SCI completes validation of its GMP manufacturing facility

CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today it has completed the validation of all critical utilities and manufacturing equipment at its GMP manufacturing facility in Maryland.

12 Jan 2010

Obese white men with diabetes face worse outcomes following radical prostatectomy

Obese white men who have both diabetes and prostate cancer have significantly worse outcomes following radical prostatectomy than do men without diabetes who undergo the same procedure, according to research from Duke University Medical Center appearing in Cancer Epidemiology, Biomarkers & Prevention

12 Jan 2010

Gunshot and stab victims face increased risk of death with prehospital spine immobilization

Immobilizing the spines of shooting and stabbing victims before they are taken to the hospital — standard procedure in Maryland and some other parts of the country — appears to double the risk of death compared to transporting patients to a trauma center without this time-consuming, on-scene medical intervention, according to a new study by Johns Hopkins researchers.

12 Jan 2010

Grossman Burn Foundation receives Fraxel re:store laser system from Solta Medical

Solta Medical, Inc. today announced the donation of a Fraxel re:store laser system to the Grossman Burn Foundation, the philanthropic arm of the Grossman Burn Center, a worldwide leader in innovative treatment and care for burn patients and their families.

12 Jan 2010

Neoprobe submits IND amendment to FDA for RIGScan CR radiopharmaceutical

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has submitted an investigational new drug (IND) amendment to the United States Food and Drug Administration (FDA) which includes the design of a proposed Phase 3 clinical trial of Neoprobe’s RIGScan® CR radiopharmaceutical.

12 Jan 2010

Detroit paper explores pain of facing breast cancer without insurance

A woman with a $7,000 annual income and $67 in the bank was diagnosed with breast cancer, leading to a week of phone calls from her surgeon to state, federal and hospital officials before a charitable agreement was struck with a medical center, the Detroit Free Press reports.

12 Jan 2010

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

PhotoMedex and Galderma Laboratories, L.P. have entered into a co-promotion agreement for Galderma’s photodynamic therapy application for the treatment of actinic keratoses (“AK”).

11 Jan 2010

Positive top-line results from Protox Therapeutics' Phase 2b study of PRX302 announced

Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.

11 Jan 2010

Sangamo BioSciences initiates two new clinical trials of ZFP Therapeutics

Sangamo BioSciences, Inc. announced the initiation of two new clinical trials of ZFP Therapeutics, a Phase 2b study in diabetic neuropathy (DN) and a Phase 1 trial in glioblastoma, as well as the renewal of $3.0 million in funding for the Phase 2b trial by the Juvenile Diabetes Research Foundation International (JDRF).

11 Jan 2010

Research into "chemical chaperone" may lead to new treatments for heart attacks

Researchers at the Indiana University and Stanford University schools of medicine have determined how a "chemical chaperone" does its job in the body, which could lead to a new class of drugs to help reduce the muscle damage caused by heart attacks.

10 Jan 2010

SIRIUS XM Radio to broadcast medical breakthroughs and milestones of the last ten years

SIRIUS XM Radio today announced that it will broadcast The Dean's List: A Decade in Medicine, an in-depth special exploring the medical breakthroughs and milestones of the last ten years hosted by Dr. Andrew Brotman, Vice Dean for Clinical Affairs, NYU Langone Medical Center, on Doctor Radio, SIRIUS XM's 24/7 health and medical channel.

9 Jan 2010

EGS announces improved clinical outcomes from its new TIF procedure

EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that data from two single-center series demonstrate improved clinical outcomes from a third-generation technique for its Transoral Incisionless Fundoplication (TIF) procedure. The data includes two case series totaling nearly 70 patients from two independent investigators, Reginald Bell, MD (Swedish Medical Center, Englewood, CO), and William Barnes, MD (Livingston Hospital and Healthcare Services, Inc., Salem, KY).

9 Jan 2010

Research determines and validates the efficacy of T category in IASLC's Staging Manual

Research released in the January 2010 issue of the Journal of Thoracic Oncology sought to determine and validate the efficacy of the recent reclassification of the T category in the IASLC's Staging Manual in Thoracic Oncology.

9 Jan 2010

Surgery News and Research

Enrollment complete in Dune Medical Devices' MarginProbe pivotal clinical trial

Frimley Park Hospital NHS Foundation Trust implements Picis software solutions

Obese patients at greater risk of developing renal cell cancer

Tocotrienol form of vitamin E prevents neural cell death and rescues the brain after stroke injury

Stem Cell Assurance announces availability of adipose-derived regenerative cell applications

University Hospitals in Cleveland selects Sectra as PACS provider

U-M Congenital Heart Center invites parents to submit queries on heart defect surgeries

CEL-SCI completes validation of its GMP manufacturing facility

Obese white men with diabetes face worse outcomes following radical prostatectomy

Gunshot and stab victims face increased risk of death with prehospital spine immobilization

Grossman Burn Foundation receives Fraxel re:store laser system from Solta Medical

Neoprobe submits IND amendment to FDA for RIGScan CR radiopharmaceutical

Detroit paper explores pain of facing breast cancer without insurance

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

Positive top-line results from Protox Therapeutics' Phase 2b study of PRX302 announced

Sangamo BioSciences initiates two new clinical trials of ZFP Therapeutics

Research into "chemical chaperone" may lead to new treatments for heart attacks

SIRIUS XM Radio to broadcast medical breakthroughs and milestones of the last ten years

EGS announces improved clinical outcomes from its new TIF procedure

Research determines and validates the efficacy of T category in IASLC's Staging Manual

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News